肝脾体积在肝硬化中的相关进展  

Related Progress in Liver and Spleen Volume in Liver Cirrhosis

作　　者：郭晓娜 韩文[1] 陈思荣 

机构地区：[1]延安大学附属医院,陕西 延安

出　　处：《临床医学进展》2022年第12期11045-11050,共6页Advances in Clinical Medicine

摘　　要：肝硬化是慢性肝病长期发展的必然结果,慢性乙型肝炎是中国肝病的一大原因。近年来,随着人群积极接种疫苗和及时抗病毒治疗以及人群饮食结构改变,酒精性肝病发病率转而呈上升趋势。对于不同类型的肝硬化,肝组织活检仍是诊断的金标准,但肝活检存在有创性,故在临床中较为受限。肝硬化的肝脏体积因病情变化随之改变,肝体积改变反映肝脏实质细胞数量变化及血流灌注机代谢能力,肝硬化患者复杂的血流变化影响脾脏体积,故肝脾体积相关指标在肝病及其并发症的存在及程度中极具潜力。Liver cirrhosis is the inevitable result of the long-term development of chronic liver disease, and chronic hepatitis B is a major cause of liver disease in China. In recent years, with the active vac-cination and timely antiviral treatment of the population, as well as the change of dietary structure of the population, the incidence of alcoholic liver disease has shown an upward trend. Liver biopsy is still the gold standard for the diagnosis of different types of liver cirrhosis, but it is invasive, so it is limited in clinical practice. The liver volume changes due to the changes in the condition of liver cirrhosis, and the changes in liver volume reflect the changes in the number of liver parenchymal cells and the metabolic capacity of blood perfusion machine. The complex blood flow changes in pa-tients with liver cirrhosis affect the spleen volume, so the liver and spleen volume related indicators have great potential in the presence and degree of liver disease and its complications.

关 键 词：肝硬化 肝脏体积 脾脏体积 研究进展 

分 类 号：R575.2[医药卫生—消化系统]